accacc2022acc2023acc2024acuteaddressingadjuvantadultsadvancedadvancingahaanalysisapproachapproachesartarthritisasco2021ashash2023ash2024asthmaatrialbasedbccbenefitbenefitsbetabetterbladderbloodbreakingbreastcancercarcinomacardiaccardiovascularcarecellchallengeschemotherapychest2024cholesterolchronicclinicalcllcombinationcontrolcontroversiescopdcoronarycovidcurrentdatadiabetesdiagnosisdiseasediseasesearlyeasdeasd2022eaueffectefficacyehaeha2025emergingersers2024escesc2021esc2022esc2023esc2024eshesh2022esh2023esh2024esmoesmo2021esmo2023esmo2024eulareular2024eventsevidencefailurefibrillationfirstfocusfreefuturegallenglpguidanceguidelineguidelineshealthhearther2hfpefhighhighlightshrhypertensionimmuneimmunotherapyimpactimproveimprovesinhibitorsinsightsinterviewisthisth2022iwlhjointkeykeynotekidneylandscapelargelateldlleukemialifelipidlongloweringlunglymphocyticlymphomamanagementmanagingmelanomametabolicmetastaticmultiplemyeloidmyelomanavigatingnovelnoveltiesobesityoptionsoutcomesoverallparadigmpatientpatientspembrolizumabpeoplephasepluspositivepostpracticepressurepreventionprimaryprogressionprostatepulmonaryrandomizedrealreceptorrenalrespiratoryresultsriskrolesabcs2024safetyscreeningsessionsevereshowsstandardstatestrategiesstudysurvivalsyndromessystemictargetedtermtherapeutictherapiestherapytreatmenttrialtrialstypeupdateupdatesvaccineversuswcclweightworldwvcdc